Navigenics, 23andMe slammed in government report
mercurynews.com
mercurynews.com
In another instance, a donor had a family history of heart disease, the report said, "yet all four companies predicted that she was at average risk for having a heart attack."
Both of these examples are incredibly weak evidence. You need statistics to find the accuracy of these products, not anecdotes. Anyway, your genes are a more accurate gauge of disease risk than family history. When a doctor asks about family history, they would prefer to take a look at your genome. It's easy to have a family history of heart attack while having an average risk yourself. If your ancestors had typical genes, but lived a different lifestyle that caused them to be more prone to heart attack, they'd have heart attacks. Hell, they could just be unlucky.
This is not currently true, though in the far future it will be. Modern genetics has been slammed (unfairly, I think) for the fact that your genetics do not increase discrimination when compared to models including family history. In other words, for virtually every human disease, family history is a better predictor of risk than is your genetic profile. I stand to benefit personally and professionally when genetic risk overtakes family history, but it simply hasn't yet.
As acangiano already posted, they obviously don't hold 'holistic' products to the same standard. I wonder what the government wants from them.
> from the gene samples they analyzed and making health predictions that didn't always jibe with their customers' actual medical conditions.
I wish they held doctors, and others practicing pseduo-medicine, to the same standards.
If the people teaching & practicing it think it's snake oil what does that say about it.
And why is it called Traditional Chinese Medicine, why not just call it medicine if it works?
http://spittoon.23andme.com/2010/07/23/gao-studies-science-n...
The only industry I can think of that basically told government "Go fuck yourselves" was wall street. Even Big Oil panders.
The response points out that there are good conclusions from these companies with which the GAO does not find exception.
Key quote from response about function the GAO didn't disparage: [We] provide information about carrier status for single gene diseases such as cystic fibrosis and Tay-Sachs disease, as well as the fact that we provide information about a customer’s likely response to certain prescription medications that have been shown in clinical trials to have differing effects and side effects depending on a person’s genetic make-up